HEALTH● LOWJul 24 · Jul 24, 2026, 7:20 PM
Outlook gains approval for ophthalmic bevacizumab for wet AMD
Seeking Alpha Tech
Outlook has gained approval for ophthalmic bevacizumab for the treatment of wet Age-related Macular Degeneration (AMD). This signifies a new therapeutic option for the condition.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH34m agoGov Radda Pledges Sustained Investment As Katsina Records Decline In Malnutrition CasesChannels TVHEALTH39m agoAmid row, Keralam’s UDF govt says cost of generic SMA drug can be cut furtherThe HinduHEALTH1h agoChildren do more sports as they grow, but move lessClarínHEALTH1h ago“We lose the oldest place in our life”: how the death of parents impacts us and how to go through griefClarín